Fundraising FoxRon Philip
InvestorBoard Director at Avalo Therapeutics
Find your path to Ron
20 people in our graph can introduce you to Ron.
Sign up to see every warm intro you have to Ron
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ron. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Ron Philip is Executive Chair of CREATE Medicines and previously CEO of Orbital Therapeutics before its acquisition by Bristol Myers Squibb. He held leadership roles at Spark Therapeutics, including CEO, where he led the launch of LUXTURNA.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Frequently asked questions
- Who is Ron Philip?
- Ron Philip is Executive Chair of CREATE Medicines and previously CEO of Orbital Therapeutics before its acquisition by Bristol Myers Squibb. He held leadership roles at Spark Therapeutics, including CEO, where he led the launch of LUXTURNA.
- Where does Ron Philip work?
- Ron Philip is Board Director at Avalo Therapeutics.